Does H5N1 avian influenza have pandemic potential? [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
On 2 July, the US government chose Moderna to develop a vaccine for the zoonotic disease ravaging farms, disrupting international food markets and, increasingly, infecting humans. The US Department of Health and Human Services (HHS) will provide approximately $176m in funding for the development of an mRNA-based pandemic influenza vaccine. Across the Atlantic, Finland has become the first country to begin vaccinations for H5N1. “Vaccinations have started this week,” Aino Pennanen, senior medical officer at Finland's Health Ministry, tells Pharmaceutical Technology . “The vaccinations are offered to people aged 18 or over who are at increased risk of avian influenza infection, such as fur farm and poultry workers, official veterinarians and laboratory workers who handle the avian influenza virus.” Finland's 20,000-dose operation – sufficient to vaccinate 10,000 people with two doses apiece – is part of an EU contract which has secured more than 40 million doses of preventative a
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the FirmGlobeNewswire
- MRNA Deadline: MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud LawsuitPR Newswire
- The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Moderna, Inc. Accesswire
- Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNAPR Newswire
- IMPORTANT MRNA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNAGlobeNewswire
MRNA
Earnings
- 8/1/24 - Beat
MRNA
Sec Filings
- 10/4/24 - Form 4
- 10/4/24 - Form 3
- 10/2/24 - Form 8-K
- MRNA's page on the SEC website